Long‐term safety of a structured transition protocol from parenteral prostanoids to selexipag in pulmonary arterial hypertension
Abstract There was no structured method for safely transition from parenteral prostanoids to oral medication. We enrolled 37 idiopathic/hereditary pulmonary arterial hypertension patients receiving triple combination therapy including parenteral prostanoids into structured transition program to oral...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Pulmonary Circulation |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/pul2.12058 |
| _version_ | 1811177982542217216 |
|---|---|
| author | Yuichi Tamura Asuka Furukawa Yudai Tamura Kenta Yamada Hirohisa Taniguchi Keiichi Fukuda Akio Kawamura Toru Satoh |
| author_facet | Yuichi Tamura Asuka Furukawa Yudai Tamura Kenta Yamada Hirohisa Taniguchi Keiichi Fukuda Akio Kawamura Toru Satoh |
| author_sort | Yuichi Tamura |
| collection | DOAJ |
| description | Abstract There was no structured method for safely transition from parenteral prostanoids to oral medication. We enrolled 37 idiopathic/hereditary pulmonary arterial hypertension patients receiving triple combination therapy including parenteral prostanoids into structured transition program to oral selexipag. Four (10.8%) patients successfully transitioned under the protocol, and all of them presented long‐term safety. |
| first_indexed | 2024-04-11T06:10:39Z |
| format | Article |
| id | doaj.art-3a4174741e134dfe8fccf65feebe0455 |
| institution | Directory Open Access Journal |
| issn | 2045-8940 |
| language | English |
| last_indexed | 2024-04-11T06:10:39Z |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Pulmonary Circulation |
| spelling | doaj.art-3a4174741e134dfe8fccf65feebe04552022-12-22T04:41:16ZengWileyPulmonary Circulation2045-89402022-01-01121n/an/a10.1002/pul2.12058Long‐term safety of a structured transition protocol from parenteral prostanoids to selexipag in pulmonary arterial hypertensionYuichi Tamura0Asuka Furukawa1Yudai Tamura2Kenta Yamada3Hirohisa Taniguchi4Keiichi Fukuda5Akio Kawamura6Toru Satoh7Pulmonary Hypertension Center International University of Health and Welfare Mita Hospital Tokyo JapanPulmonary Hypertension Center International University of Health and Welfare Mita Hospital Tokyo JapanDepartment of Cardiology International University of Health and Welfare School of Medicine Narita JapanDepartment of Cardiology International University of Health and Welfare School of Medicine Narita JapanDepartment of Cardiology International University of Health and Welfare School of Medicine Narita JapanDepartment of Cardiology Keio University School of Medicine Tokyo JapanDepartment of Cardiology International University of Health and Welfare School of Medicine Narita JapanDepartment of Cardiology Kyorin University School of Medicine Tokyo JapanAbstract There was no structured method for safely transition from parenteral prostanoids to oral medication. We enrolled 37 idiopathic/hereditary pulmonary arterial hypertension patients receiving triple combination therapy including parenteral prostanoids into structured transition program to oral selexipag. Four (10.8%) patients successfully transitioned under the protocol, and all of them presented long‐term safety.https://doi.org/10.1002/pul2.12058prostanoidspulmonary arterial hypertensiontransition therapy |
| spellingShingle | Yuichi Tamura Asuka Furukawa Yudai Tamura Kenta Yamada Hirohisa Taniguchi Keiichi Fukuda Akio Kawamura Toru Satoh Long‐term safety of a structured transition protocol from parenteral prostanoids to selexipag in pulmonary arterial hypertension Pulmonary Circulation prostanoids pulmonary arterial hypertension transition therapy |
| title | Long‐term safety of a structured transition protocol from parenteral prostanoids to selexipag in pulmonary arterial hypertension |
| title_full | Long‐term safety of a structured transition protocol from parenteral prostanoids to selexipag in pulmonary arterial hypertension |
| title_fullStr | Long‐term safety of a structured transition protocol from parenteral prostanoids to selexipag in pulmonary arterial hypertension |
| title_full_unstemmed | Long‐term safety of a structured transition protocol from parenteral prostanoids to selexipag in pulmonary arterial hypertension |
| title_short | Long‐term safety of a structured transition protocol from parenteral prostanoids to selexipag in pulmonary arterial hypertension |
| title_sort | long term safety of a structured transition protocol from parenteral prostanoids to selexipag in pulmonary arterial hypertension |
| topic | prostanoids pulmonary arterial hypertension transition therapy |
| url | https://doi.org/10.1002/pul2.12058 |
| work_keys_str_mv | AT yuichitamura longtermsafetyofastructuredtransitionprotocolfromparenteralprostanoidstoselexipaginpulmonaryarterialhypertension AT asukafurukawa longtermsafetyofastructuredtransitionprotocolfromparenteralprostanoidstoselexipaginpulmonaryarterialhypertension AT yudaitamura longtermsafetyofastructuredtransitionprotocolfromparenteralprostanoidstoselexipaginpulmonaryarterialhypertension AT kentayamada longtermsafetyofastructuredtransitionprotocolfromparenteralprostanoidstoselexipaginpulmonaryarterialhypertension AT hirohisataniguchi longtermsafetyofastructuredtransitionprotocolfromparenteralprostanoidstoselexipaginpulmonaryarterialhypertension AT keiichifukuda longtermsafetyofastructuredtransitionprotocolfromparenteralprostanoidstoselexipaginpulmonaryarterialhypertension AT akiokawamura longtermsafetyofastructuredtransitionprotocolfromparenteralprostanoidstoselexipaginpulmonaryarterialhypertension AT torusatoh longtermsafetyofastructuredtransitionprotocolfromparenteralprostanoidstoselexipaginpulmonaryarterialhypertension |